human cd34 pe conjugated antibody Search Results


93
R&D Systems human cd34
Human Cd34, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd34+pe+conjugated+antibody/pm37019470-85-146-148?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
human cd34 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

94
R&D Systems cd34
FIGURE 2. Limited self-renewal of mesenchymal stem/ stromal (MSCs) from breast cancer patients (BCPs). (A) <t>Colony</t> <t>forming</t> <t>units-fibroblastic</t> (CFU-F) size observed for a BCP. (B) CFU-F size observed for a healthy volunteer (HV). Giemsa staining (40 X). (C) CFU-F assay: number of CFU-F observed in BCPs (n = 14) and HVs (n = 7). Values are expressed as mean ± SE. Statistical analysis: unpaired t- test with Welch’s correction. Asterisks indicate a significant difference (***p = 0.0004). (D) Number of stromal cells per microscope optical field (stromal cell density, SCD) in each CFU-F from BM of BCPs (n = 13) and HVs (n = 6). Statistical analysis: nonparametric Mann–Whitney test. Asterisks indicate a significant difference (***p = 0.0040).
Cd34, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cd34+pe+conjugated+antibody/pm37305388-89-82-85?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
cd34 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

N/A
Mouse anti-Human/Rat CD34 Antibody [PE Conjugated]
  Buy from Supplier

N/A
The Human CD34 PE conjugated Antibody from R D Systems is a mouse monoclonal antibody to CD34 This antibody reacts with human The Human CD34 PE conjugated Antibody has been validated for the following applications
  Buy from Supplier




Image Search Results


FIGURE 2. Limited self-renewal of mesenchymal stem/ stromal (MSCs) from breast cancer patients (BCPs). (A) Colony forming units-fibroblastic (CFU-F) size observed for a BCP. (B) CFU-F size observed for a healthy volunteer (HV). Giemsa staining (40 X). (C) CFU-F assay: number of CFU-F observed in BCPs (n = 14) and HVs (n = 7). Values are expressed as mean ± SE. Statistical analysis: unpaired t- test with Welch’s correction. Asterisks indicate a significant difference (***p = 0.0004). (D) Number of stromal cells per microscope optical field (stromal cell density, SCD) in each CFU-F from BM of BCPs (n = 13) and HVs (n = 6). Statistical analysis: nonparametric Mann–Whitney test. Asterisks indicate a significant difference (***p = 0.0040).

Journal: Oncology research

Article Title: Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.

doi: 10.32604/or.2023.028104

Figure Lengend Snippet: FIGURE 2. Limited self-renewal of mesenchymal stem/ stromal (MSCs) from breast cancer patients (BCPs). (A) Colony forming units-fibroblastic (CFU-F) size observed for a BCP. (B) CFU-F size observed for a healthy volunteer (HV). Giemsa staining (40 X). (C) CFU-F assay: number of CFU-F observed in BCPs (n = 14) and HVs (n = 7). Values are expressed as mean ± SE. Statistical analysis: unpaired t- test with Welch’s correction. Asterisks indicate a significant difference (***p = 0.0004). (D) Number of stromal cells per microscope optical field (stromal cell density, SCD) in each CFU-F from BM of BCPs (n = 13) and HVs (n = 6). Statistical analysis: nonparametric Mann–Whitney test. Asterisks indicate a significant difference (***p = 0.0040).

Article Snippet: Phenotypic characterization of MSCs from the third subculture MSCs were suspended in PBS containing 1% bovine serum albumin (BSA, A7030, Sigma, Saint Louis, MO, USA), and labeled with the primary Ab against the following human antigens: CD105 (cat. FAB10971V, R&D Systems Inc., Minneapolis, MN, USA), CD90 (cat. FAB2067G, R&D Systems Inc., Minneapolis, MN, USA), CD73 (cat. FAB5795A, R&D Systems Inc., Minneapolis, MN, USA), CD79a (cat. FAB69201G, R&D Systems Inc., Minneapolis, MN, USA), CD11b (cat. FAB1699V, R&D Systems Inc., Minneapolis, MN, USA), and CD34 (cat. FAB7227P, R&D Systems Inc., Minneapolis, MN, USA).

Techniques: Staining, Microscopy, MANN-WHITNEY

FIGURE 3. Altered morphology of mesenchymal stem/stromal (MSCs) from breast cancer patients (BCPs). (A) and (B) MSCs size and shape observed in colony forming units-fibroblastic (CFU-F) assay of a BCP and a healthy volunteer (HV). Giemsa staining (200). (C) Area of stromal cells in typical regions of each CFU-F culture from BCPs (n = 13) and HVs (n = 6). (D) Longitudinal axis of stromal cells in typical regions of CFU-F cultures from BCPs (n = 13) and HVs (n = 6). (E) Horizontal axis stromal cells in typical regions of CFU-F culture from BCPs (n = 13) and HVs (n = 6). The values are expressed as Mean ± SE. Statistical analysis: nonparametric Mann–Whitney test. Asterisks indicate a significant difference (****p < 0.0001 and ***p < 0.0003).

Journal: Oncology research

Article Title: Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.

doi: 10.32604/or.2023.028104

Figure Lengend Snippet: FIGURE 3. Altered morphology of mesenchymal stem/stromal (MSCs) from breast cancer patients (BCPs). (A) and (B) MSCs size and shape observed in colony forming units-fibroblastic (CFU-F) assay of a BCP and a healthy volunteer (HV). Giemsa staining (200). (C) Area of stromal cells in typical regions of each CFU-F culture from BCPs (n = 13) and HVs (n = 6). (D) Longitudinal axis of stromal cells in typical regions of CFU-F cultures from BCPs (n = 13) and HVs (n = 6). (E) Horizontal axis stromal cells in typical regions of CFU-F culture from BCPs (n = 13) and HVs (n = 6). The values are expressed as Mean ± SE. Statistical analysis: nonparametric Mann–Whitney test. Asterisks indicate a significant difference (****p < 0.0001 and ***p < 0.0003).

Article Snippet: Phenotypic characterization of MSCs from the third subculture MSCs were suspended in PBS containing 1% bovine serum albumin (BSA, A7030, Sigma, Saint Louis, MO, USA), and labeled with the primary Ab against the following human antigens: CD105 (cat. FAB10971V, R&D Systems Inc., Minneapolis, MN, USA), CD90 (cat. FAB2067G, R&D Systems Inc., Minneapolis, MN, USA), CD73 (cat. FAB5795A, R&D Systems Inc., Minneapolis, MN, USA), CD79a (cat. FAB69201G, R&D Systems Inc., Minneapolis, MN, USA), CD11b (cat. FAB1699V, R&D Systems Inc., Minneapolis, MN, USA), and CD34 (cat. FAB7227P, R&D Systems Inc., Minneapolis, MN, USA).

Techniques: Staining, MANN-WHITNEY